uBriGene Biosciences Inc. is a world-class gene therapy CDMO supporting customers from concept to commercialization. Located on the campus of University of British Columbia in Vancouver, Canada, uBriGene is dedicated to providing one-stop viral vector–based CDMO services for research and clinical applications. The company has established integrated CDMO platforms that provide GMP plasmids, AAVs, lentiviruses, cell therapy manufacturing, and cell banking. uBriGene is a trusted global partner with additional facilities in the United States and China.
Visit Company Website
